(Q73126787)

English

E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer

scientific article published on 01 February 2003

Statements

E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit